MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00774-025-01682-z

Медицинская библиотека · Journal of bone and mineral metabolism · 2026

Association of serum magnesium levels and calcimimetic use: fractures and cardiovascular events in Japanese haemodialysis patients.

Saito Tomohiro, Mizobuchi Masahide, Yoshida Kiryu, Kato Tadashi, Abe Kazuki, Takezaki Toshiaki, Kato Noriyuki, Inoue Eisuke, Ogata Hiroaki, Koiwa Fumihiko, Honda Hirokazu

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Though low serum magnesium (Mg) levels are associated with adverse outcomes in patients on haemodialysis, the interaction with calcimimetics remains uncertain. We hypothesized a potential interaction between serum Mg levels and calcimimetic use in cardiovascular events (CVEs), all-cause mortality, and new fractures during follow-up in patients on haemodialysis.

MATERIALS AND

METHODS

This single-centre retrospective cohort included 399 Japanese adults on maintenance haemodialysis, followed for ≤ 5 years. Cox models with time-dependent serum Mg levels and calcimimetic usage interaction adjusted for clinicodemographic and biochemical covariates.

RESULTS

At baseline, 205 patients (51.4%) were prescribed calcimimetics (median serum Mg, 2.5 mg/dL). The mean observational period was 40.6 months, and 122 CVEs, 159 all-cause mortality, and 69 new fractures occurred (incidence rates: 0.09, 0.10-, and 0.05 per patient-year), respectively. The time-dependent model showed serum Mg < 2.4 mg/dL was associated with a markedly higher risk for new fractures in calcimimetic-naïve patients. Serum Mg levels were not significantly associated with CVEs and all-cause mortality, regardless of calcimimetic usage. The restricted cubic spline curve demonstrated linear inverse trends of serum Mg levels with all-cause mortality and new fractures in calcimimetic-naïve patients. However, no significant interaction between Mg and calcimimetic use was observed for any outcome.

CONCLUSION

We did not detect a statistically significant interaction between serum Mg levels and calcimimetic use. Nonetheless, low serum Mg (< 2.4 mg/dL) was associated with a higher risk of fractures, particularly among calcimimetic-naïve patients. Thus, low serum Mg is a potentially modifiable risk marker associated with fracture risk, particularly in calcimimetic-naïve patients.

Для цитирования: Saito Tomohiro, Mizobuchi Masahide, Yoshida Kiryu, Kato Tadashi, Abe Kazuki, Takezaki Toshiaki, Kato Noriyuki, Inoue Eisuke, Ogata Hiroaki, Koiwa Fumihiko, Honda Hirokazu. Association of serum magnesium levels and calcimimetic use: fractures and cardiovascular events in Japanese haemodialysis patients.. Journal of bone and mineral metabolism. 2026. DOI: 10.1007/s00774-025-01682-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.